文献速递神经肿瘤神经重症

成人恶性脑肿瘤的姑息治疗与临终关怀

Palliative care and end-of-life care in adults with malignant brain tumors.
PubMed 文献 · Neuro Oncol · 2023-01-01

本系统综述基于2017年欧洲神经肿瘤学会(EANO)成人恶性脑肿瘤姑息治疗指南,检索2016至2021年文献,聚焦症状管理、照护者需求、早期姑息治疗和临终关怀四个主题,共纳入140篇文章。新见解包括海马回避和立体定向放射外科降低脑转移患者神经认知下降风险,左乙拉西坦作为一线单药抗癫痫药物减少胶质瘤患者癫痫发作优于丙戊酸,拉考沙胺和吡仑帕奈作为添加抗癫痫药物似乎耐受良好且有效,并提出了高级别胶质瘤患者及其照护者的姑息与支持治疗综合框架。随机对照试验未显示任何药物能显著改善疲劳或神经认知。结论认为多数推荐不变,早期姑息治疗干预至关重要,亟需针对疼痛、疲劳、精神症状及早期姑息治疗时机的干预性研究。

要点

  • 海马回避和立体定向放射外科可降低脑转移患者神经认知下降风险。
  • 左乙拉西坦作为一线单药抗癫痫药物减少胶质瘤患者癫痫发作优于丙戊酸。
  • 拉考沙胺和吡仑帕奈作为添加抗癫痫药物似乎耐受良好且有效。

核心结论

  • 自2017年EANO姑息治疗指南以来,症状管理和临终关怀方面有新见解,但多数推荐保持不变。
  • 早期姑息治疗干预对于及时明确照护目标和减轻症状负担至关重要。
  • 亟需针对疼痛、疲劳和精神症状以及早期姑息治疗时机的干预性研究。

研究设计与样本

  • 系统综述,检索2016至2021年文献,聚焦症状管理、照护者需求、早期姑息治疗和临终关怀四个主题。
  • 由神经肿瘤学姑息治疗国际专家组综合文献并报告最相关更新,共纳入140篇文章。

主要发现

  • 海马回避和立体定向放射外科导致脑转移患者神经认知下降风险较低。
  • 左乙拉西坦作为一线单药抗癫痫药物减少胶质瘤患者癫痫发作比丙戊酸更有效。
  • 拉考沙胺和吡仑帕奈作为添加抗癫痫药物似乎耐受良好且有效。
  • 提出了高级别胶质瘤患者及其照护者的姑息与支持治疗综合框架。
  • 随机对照试验未显示任何药物能显著改善疲劳或神经认知。

关键数值与推荐

  • 左乙拉西坦作为一线单药抗癫痫药物减少胶质瘤患者癫痫发作优于丙戊酸。
  • 拉考沙胺和吡仑帕奈似乎耐受良好且有效的添加抗癫痫药物。
  • 海马回避和立体定向放射外科导致脑转移患者神经认知下降风险较低。
  • 随机对照试验未显示任何药物能显著改善疲劳或神经认知。

临床怎么用

  • 早期姑息治疗干预对于及时明确照护目标和减轻症状负担至关重要。

局限性

  • 亟需针对疼痛、疲劳和精神症状以及早期姑息治疗时机的干预性研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This systematic review provides updated insights, from the published literature in the past 5 years, based on the 2017 European Association of Neuro-Oncology (EANO) guidelines for palliative care in adults with malignant brain tumors. It provides an overview of palliative care options, including during the end-of-life phase for patients with malignant brain tumors. METHODS: A systematic literature search was conducted from 2016 to 2021 focusing on four main topics: (1) symptom management, (2) caregiver needs, (3) early palliative care, and (4) care in the end-of-life phase. An international panel of palliative care experts in neuro-oncology synthesized the literature and reported the most relevant updates. A total of 140 articles were included. RESULTS: New insights include that: Hippocampal avoidance and stereotactic radiosurgery results in a lower risk of neurocognitive decline in patients with brain metastases; levetiracetam is more efficacious in reducing seizures than valproic acid as first-line monotherapy antiseizure drug (ASD) in glioma patients; lacosamide and perampanel seem well-tolerated and efficacious add-on ASDs; and a comprehensive framework of palliative and supportive care for high-grade glioma patients and their caregivers was proposed. No pharmacological agents have been shown in randomized controlled trials to significantly improve fatigue or neurocognition. CONCLUSIONS: Since the 2017 EANO palliative care guidelines, new insights have been reported regarding symptom management and end-of-life care, however, most recommendations remain unchanged. Early palliative care interventions are essential to define goals of care and minimize symptom burden in a timely fashion. Interventional studies that address pain, fatigue, and psychiatric symptoms as well as (the timing of) early palliative care are urgently needed.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Koekkoek JAF, van der Meer PB, Pace A, et al. Palliative care and end-of-life care in adults with malignant brain tumors. Neuro Oncol. 2023. PMID: 36271873. doi:10.1093/neuonc/noac216

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。